Palliative Care for Esophageal Cancer: Symptom Management and Quality of Life

Palliative care for esophageal cancer focuses on symptom control, nutritional support, and psychosocial well-being—not cure. Interventions are tailored to disease stage, performance status, and patient goals.

Multimodal Palliative Options

Domain	Interventions	Indications
Pain	Opioids (WHO stepwise ladder), adjuvants (gabapentin for neuropathic), celiac plexus block	Tumor invasion, metastases, treatment toxicity
Nausea/Vomiting	5-HT3 antagonists (ondansetron), NK1 antagonists (aprepitant), steroids, metoclopramide	Chemo/radiation, gastric obstruction, medications
Dysphagia/Nutrition	Self-expanding metal stents (SEMS), laser/argon plasma coagulation, dilation, PEG/J-tube, TPN	Intrinsic/extrinsic obstruction; maintains oral intake if possible
Airway protection	Tracheoesophageal fistula stenting, suction, positioning	Fistula prevention/management
Bleeding	Endoscopic hemostasis (clips, argon plasma), radiation, tranexamic acid	Tumor erosion into vessels
Local tumor control	Palliative RT (30 Gy/10 fx), brachytherapy, chemo (taxane/platinum/5-FU based)	Symptomatic primary/metastases; improves dysphagia/pain in 50–70%
Psychosocial	Counseling, support groups, advance care planning, hospice referral	Existential distress, caregiver burden, goals-of-care alignment

Key Principles

• Early integration: Palliative care at diagnosis improves quality of life, mood, and even survival (Temel et al., NEJM 2010).
• Stent first for obstruction: SEMS allows rapid oral intake recovery; radiation/chemo for durability.
• Nutrition ≠ TPN default: Enteral > parenteral; preserve gut function whenever possible.
• Shared decision-making: Revisit goals at each transition.